Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:32:25.692Z.
Calculation as of: 2026-10-06T20:32:25.692Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7a446221ee70341de49d615c46e15f9be625c30a72cedc9ff9e6473dbc59ae23
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
NRx Pharmaceuticals, Inc.
Market Cap
$127.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$127.98M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$124.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$124.18M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$130.79M
Operating Cash Flow Yield
21.59%
TTM Avg
12.96%
3Y Avg
8.76%
5Y Avg
8.76%
Market Cap
$131.21M
Operating Cash Flow Yield
0.97%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
Market Cap
$122.66M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$132.03M
Operating Cash Flow Yield
N/A
TTM Avg
6.01%
3Y Avg
5.49%
5Y Avg
5.49%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $127.29M | N/A | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | N/A | N/A | N/A | N/A |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 21.59% | 12.96% | 8.76% | 8.76% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 0.97% | 3.24% | 4.92% | 5.15% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A | 6.01% | 5.49% | 5.49% |
| BGM Group Ltd. (BGM)vs › | $122.43M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
